ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CTEC Convatec Group Plc

283.60
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 283.60 282.20 282.40 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 2.14B 130.3M 0.0636 44.40 5.79B

ConvaTec Group PLC AGM Special Resolutions at NSM (7343N)

11/05/2018 7:00am

UK Regulatory


Convatec (LSE:CTEC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 7343N

ConvaTec Group PLC

11 May 2018

Special Resolutions available at NSM

11 May 2018

ConvaTec Group Plc

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting on 10 May 2018 and the results of the poll were published that day.

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the annual general meeting have been submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.

For further information, please contact Clare Bates, Company Secretary (0118 952 8100).

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

Enquiries

Analysts and Investors

   John Crosse, VP Investor Relations, ConvaTec                              +44 (0)7500 141 435 
   Kirsty Law, Director Investor Relations, ConvaTec                          +44 (0)7470 909 582 

investorrelations@convatec.com

Media

   Bobby Leach, VP Group Corporate Affairs, ConvaTec                    +44 (0)7770 842 226 

Rebecca Fitchett, Finsbury +44 (0)207 251 3801

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

# # #

END

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGGGUUUAUPRGBU

(END) Dow Jones Newswires

May 11, 2018 02:00 ET (06:00 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart

Your Recent History

Delayed Upgrade Clock